Celyad SA ADR buy melinda
Start price
17.03.17
/
50%
€19.53
Target price
30.03.17
€20.93
Performance (%)
11.61%
End price
30.03.17
€21.79
Summary
This prediction ended on 30.03.17 with a price of €21.79. The prediction had a final performance of 11.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by melinda for this prediction
In the thread Celyad SA ADR diskutieren
BIOPHARMA
A +
(Zielkurs erreicht)


